| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
8,000 |
6,428 |
$375K |
| 93306 |
|
3,681 |
3,219 |
$279K |
| 78452 |
|
671 |
557 |
$94K |
| 99204 |
|
970 |
794 |
$84K |
| 99223 |
Prolong inpt eval add15 m |
1,127 |
866 |
$73K |
| 99233 |
Prolong inpt eval add15 m |
1,034 |
258 |
$47K |
| 99232 |
|
1,644 |
304 |
$43K |
| J2785 |
Injection, regadenoson, 0.1 mg |
410 |
350 |
$38K |
| 93000 |
|
4,672 |
3,868 |
$30K |
| 93015 |
|
732 |
623 |
$22K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
714 |
583 |
$16K |
| 99215 |
Prolong outpt/office vis |
100 |
92 |
$7K |
| 99213 |
|
42 |
35 |
$2K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
136 |
127 |
$1K |